Union Textiles Minister Giriraj Singh on Sunday, 31 May 2026 highlighted the establishment of a Medical Textiles Testing Laboratory at the Andhra Pradesh MedTech Zone (AMTZ) in Visakhapatnam, describing it as a significant step toward making India self-reliant and globally competitive in the medical textiles and MedTech sectors.

Context

In his post, the Minister stated that the newly set-up lab at AMTZ, Visakhapatnam will ensure testing of surgical gowns, masks, PPE kits, drapes, and other medical textile products for quality, safety, and conformance with global standards. He wrote: 'यह पहल भारत को मेडिकल टेक्सटाइल्स और मेडटेक क्षेत्र में आत्मनिर्भर बनाने के साथ-साथ वैश्विक स्तर पर अधिक प्रतिस्पर्धी बनाने की दिशा में एक महत्वपूर्ण कदम है' — ('This initiative is an important step toward making India self-reliant in medical textiles and the MedTech sector, as well as more competitive at the global level.')

AMTZ is an integrated medical technology manufacturing and testing facility in Visakhapatnam, Andhra Pradesh, and has emerged as a key node for health-related industrial infrastructure in India.

Policy Backdrop

The announcement fits within the framework of the National Technical Textiles Mission (NTTM), approved in 2020 with an outlay of Rs 1,480 crore, which specifically earmarked components for research, testing infrastructure, and production of technical textiles including the medical textiles segment. The mission was designed to position India as a global leader in technical textiles — a category that encompasses surgical and protective textile products.

The COVID-19 disruptions of 2020 exposed India's dependence on imported PPE, masks, and surgical textiles, prompting the Ministry of Textiles to introduce production-linked incentives and invest in quality testing infrastructure to reduce that dependence. The AMTZ lab represents a continuation of that policy response. Both initiatives sit under the broader Atmanirbhar Bharat programme, launched in 2020, which seeks to build domestic value chains across sectors including health-related manufacturing.

Stakeholders and Impact

The primary beneficiaries of a dedicated testing laboratory at AMTZ include domestic medical textile manufacturers, MedTech exporters, and healthcare procurement agencies that require certified, globally compliant products. Access to in-country testing reduces turnaround time and cost for manufacturers seeking international certifications, which has historically been a barrier to export competitiveness.

For Andhra Pradesh, the facility reinforces Visakhapatnam's role as a hub for technical textiles and MedTech infrastructure. Manufacturers of surgical gowns, PPE kits, and hospital drapes stand to benefit most directly, as quality certification against global standards is a prerequisite for accessing procurement contracts in regulated markets such as the European Union and the United States.

What's Next

Attention will now turn to the operational status of the lab, the specific testing protocols it will be notified to conduct, and whether its establishment translates into a measurable rise in BIS or internationally recognised certifications for Indian medical textile products. Industry observers will also watch whether the facility is eventually accredited under international frameworks that allow test reports to be accepted directly by foreign regulators.

The Ministry of Textiles is expected to use the AMTZ lab as a model for expanding specialised testing infrastructure to other technical textiles clusters across India, as the government seeks to scale up exports in a segment where global demand — particularly for medical-grade protective textiles — has grown significantly since 2020.